Wellnex Life’s Strategic Shifts Shape FY24 Results
Company Announcements

Wellnex Life’s Strategic Shifts Shape FY24 Results

Wellnex Life Ltd (AU:WNX) has released an update.

Wellnex Life Ltd reported a revenue decline of 39.3% to $16.9 million and an increased loss of 6.4% to $14.7 million for FY24, attributed to strategic shifts including exiting low-margin brokerage services and acquiring Pain Away. Despite lower revenues, gross margins improved notably from 17% to 30%, and are expected to rise further in FY25. The company is preparing for a dual listing on the London Stock Exchange and anticipates strong revenue growth driven by new brands and expansion.

For further insights into AU:WNX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskWellnex Life Plans LSE Listing to Expand Globally
TipRanks Australian Auto-Generated NewsdeskWellnex Life Prepares for Annual General Meeting
TipRanks Australian Auto-Generated NewsdeskWellnex Life Extends Offer Period Amid Growth Strategy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App